Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine phosphatase activity	PTPRG PTPRM PTPRZ1	1.22e-04	17	116	3	GO:0005001
GeneOntologyMolecularFunction	transmembrane receptor protein phosphatase activity	PTPRG PTPRM PTPRZ1	1.22e-04	17	116	3	GO:0019198
GeneOntologyMolecularFunction	dinitrosyl-iron complex binding	GSTA1 GSTA2	3.31e-04	5	116	2	GO:0035731
Domain	YDG	UHRF1 UHRF2	3.82e-05	2	116	2	PS51015
Domain	TTD	UHRF1 UHRF2	3.82e-05	2	116	2	PF12148
Domain	SAD_SRA	UHRF1 UHRF2	3.82e-05	2	116	2	PF02182
Domain	SRA	UHRF1 UHRF2	3.82e-05	2	116	2	SM00466
Domain	-	UHRF1 UHRF2	3.82e-05	2	116	2	2.30.280.10
Domain	NLGN4	NLGN4Y NLGN4X	3.82e-05	2	116	2	IPR030025
Domain	TTD_dom	UHRF1 UHRF2	3.82e-05	2	116	2	IPR021991
Domain	SRA_YDG	UHRF1 UHRF2	3.82e-05	2	116	2	IPR003105
Domain	PTPc	PTPN7 PTPRG PTPRM PTPRZ1	7.14e-05	36	116	4	SM00194
Domain	TYR_PHOSPHATASE_PTP	PTPN7 PTPRG PTPRM PTPRZ1	9.82e-05	39	116	4	PS50055
Domain	PTPase_domain	PTPN7 PTPRG PTPRM PTPRZ1	1.20e-04	41	116	4	IPR000242
Domain	Y_phosphatase	PTPN7 PTPRG PTPRM PTPRZ1	1.20e-04	41	116	4	PF00102
Domain	Pkinase_Tyr	PDGFRB SRC LCK AATK FER MAP3K13	1.54e-04	129	116	6	PF07714
Domain	Ser-Thr/Tyr_kinase_cat_dom	PDGFRB SRC LCK AATK FER MAP3K13	2.22e-04	138	116	6	IPR001245
Domain	PROTEIN_KINASE_TYR	PDGFRB SRC LCK AATK FER	3.47e-04	97	116	5	PS00109
Domain	Tyr_kinase_AS	PDGFRB SRC LCK AATK FER	3.47e-04	97	116	5	IPR008266
Domain	GST_alpha	GSTA1 GSTA2	3.78e-04	5	116	2	IPR003080
Domain	HSR	SP110 SP140L	3.78e-04	5	116	2	PS51414
Domain	Nlgn	NLGN4Y NLGN4X	3.78e-04	5	116	2	IPR000460
Domain	HSR	SP110 SP140L	3.78e-04	5	116	2	PF03172
Domain	HSR_dom	SP110 SP140L	3.78e-04	5	116	2	IPR004865
Domain	PTPc_motif	PTPN7 PTPRG PTPRM PTPRZ1	4.94e-04	59	116	4	SM00404
Domain	Tyr_Pase_cat	PTPN7 PTPRG PTPRM PTPRZ1	4.94e-04	59	116	4	IPR003595
Domain	UCH	USP34 USP24 PAN2 USP15	9.96e-04	71	116	4	PF00443
Domain	SAND_dom	SP110 SP140L	1.04e-03	8	116	2	IPR000770
Domain	DHC_N1	DYNC2H1 DNAH2	1.04e-03	8	116	2	PF08385
Domain	SAND	SP110 SP140L	1.04e-03	8	116	2	PF01342
Domain	A2M_N_2	A2ML1 C5	1.04e-03	8	116	2	SM01359
Domain	-	A2ML1 C5	1.04e-03	8	116	2	2.60.40.690
Domain	Dynein_heavy_dom-1	DYNC2H1 DNAH2	1.04e-03	8	116	2	IPR013594
Domain	A2M_recep	A2ML1 C5	1.04e-03	8	116	2	SM01361
Domain	A2M	A2ML1 C5	1.04e-03	8	116	2	SM01360
Domain	SAND	SP110 SP140L	1.04e-03	8	116	2	PS50864
Domain	SAND	SP110 SP140L	1.04e-03	8	116	2	SM00258
Domain	USP_3	USP34 USP24 PAN2 USP15	1.05e-03	72	116	4	PS50235
Domain	USP_dom	USP34 USP24 PAN2 USP15	1.05e-03	72	116	4	IPR028889
Domain	Peptidase_C19_UCH	USP34 USP24 PAN2 USP15	1.05e-03	72	116	4	IPR001394
Domain	Tyr_Pase_AS	PTPN7 PTPRG PTPRM PTPRZ1	1.11e-03	73	116	4	IPR016130
Domain	PHD	SP110 SP140L UHRF1 UHRF2	1.22e-03	75	116	4	PF00628
Domain	Znf_PHD-finger	SP110 SP140L UHRF1 UHRF2	1.48e-03	79	116	4	IPR019787
Domain	A2M	A2ML1 C5	1.67e-03	10	116	2	PF00207
Domain	A2M_N_2	A2ML1 C5	1.67e-03	10	116	2	IPR011625
Domain	A2M_comp	A2ML1 C5	1.67e-03	10	116	2	IPR011626
Domain	A2M_recep	A2ML1 C5	1.67e-03	10	116	2	PF07677
Domain	A2M_comp	A2ML1 C5	1.67e-03	10	116	2	PF07678
Domain	A2M_N	A2ML1 C5	1.67e-03	10	116	2	PF01835
Domain	A2M_N	A2ML1 C5	1.67e-03	10	116	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	A2ML1 C5	1.67e-03	10	116	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	A2ML1 C5	1.67e-03	10	116	2	PS00477
Domain	A2M_N_2	A2ML1 C5	1.67e-03	10	116	2	PF07703
Domain	Macroglobln_a2	A2ML1 C5	1.67e-03	10	116	2	IPR001599
Domain	-	RNF213 TRIM64 SP110 TRIM59 TRIM64B SP140L UHRF1 UBR3 UHRF2	1.95e-03	449	116	9	3.30.40.10
Domain	TYR_PHOSPHATASE_1	PTPN7 PTPRG PTPRM PTPRZ1	2.03e-03	86	116	4	PS00383
Domain	AAA	DYNC2H1 DNAH2 PEX6 RNF213 ABCG4	2.05e-03	144	116	5	SM00382
Domain	AAA+_ATPase	DYNC2H1 DNAH2 PEX6 RNF213 ABCG4	2.05e-03	144	116	5	IPR003593
Domain	TYR_PHOSPHATASE_dom	PTPN7 PTPRG PTPRM PTPRZ1	2.12e-03	87	116	4	IPR000387
Domain	TYR_PHOSPHATASE_2	PTPN7 PTPRG PTPRM PTPRZ1	2.12e-03	87	116	4	PS50056
Domain	Tyr_kinase_cat_dom	PDGFRB SRC LCK FER	2.21e-03	88	116	4	IPR020635
Domain	TyrKc	PDGFRB SRC LCK FER	2.21e-03	88	116	4	SM00219
Domain	Znf_RING/FYVE/PHD	RNF213 TRIM64 SP110 TRIM59 TRIM64B SP140L UHRF1 UBR3 UHRF2	2.27e-03	459	116	9	IPR013083
Domain	PHD	SP110 SP140L UHRF1 UHRF2	2.30e-03	89	116	4	SM00249
Domain	-	SP110 SP140L	2.42e-03	12	116	2	3.10.390.10
Domain	-	A2ML1 C5	2.42e-03	12	116	2	1.50.10.20
Domain	SAND_dom-like	SP110 SP140L	2.42e-03	12	116	2	IPR010919
Domain	Znf_PHD	SP110 SP140L UHRF1 UHRF2	2.49e-03	91	116	4	IPR001965
Domain	-	PTPN7 PTPRG PTPRM PTPRZ1	2.59e-03	92	116	4	3.90.190.10
Domain	ZF_RING_2	RNF213 TRIM64 TRIM59 TRIM64B UHRF1 UBR3 UHRF2	2.60e-03	298	116	7	PS50089
Domain	zf-C3HC4	RNF213 TRIM64 TRIM59 TRIM64B UBR3 UHRF2	2.70e-03	223	116	6	PF00097
Domain	Carboxylesterase_B_CS	NLGN4Y NLGN4X	2.85e-03	13	116	2	IPR019819
Domain	NHL	NHLRC2 TENM4	2.85e-03	13	116	2	PS51125
Domain	ZF_PHD_2	SP110 SP140L UHRF1 UHRF2	2.91e-03	95	116	4	PS50016
Domain	ZF_PHD_1	SP110 SP140L UHRF1 UHRF2	3.02e-03	96	116	4	PS01359
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH2	3.31e-03	14	116	2	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DNAH2	3.31e-03	14	116	2	IPR024743
Domain	CARBOXYLESTERASE_B_2	NLGN4Y NLGN4X	3.31e-03	14	116	2	PS00941
Domain	Dynein_heavy_dom-2	DYNC2H1 DNAH2	3.31e-03	14	116	2	IPR013602
Domain	DHC_N2	DYNC2H1 DNAH2	3.31e-03	14	116	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 DNAH2	3.31e-03	14	116	2	IPR011704
Domain	COesterase	NLGN4Y NLGN4X	3.31e-03	14	116	2	PF00135
Domain	MT	DYNC2H1 DNAH2	3.31e-03	14	116	2	PF12777
Domain	AAA_8	DYNC2H1 DNAH2	3.31e-03	14	116	2	PF12780
Domain	CarbesteraseB	NLGN4Y NLGN4X	3.31e-03	14	116	2	IPR002018
Domain	AAA_5	DYNC2H1 DNAH2	3.31e-03	14	116	2	PF07728
Domain	Prot-tyrosine_phosphatase-like	PTPN7 PTPRG PTPRM PTPRZ1	3.38e-03	99	116	4	IPR029021
Domain	Znf_RING_CS	TRIM64 TRIM59 TRIM64B UHRF1 UHRF2	3.51e-03	163	116	5	IPR017907
Domain	SH2	SRC LCK STAT5A FER	3.63e-03	101	116	4	PF00017
Domain	DHC_fam	DYNC2H1 DNAH2	3.81e-03	15	116	2	IPR026983
Domain	Dynein_heavy	DYNC2H1 DNAH2	3.81e-03	15	116	2	PF03028
Domain	Dynein_heavy_dom	DYNC2H1 DNAH2	3.81e-03	15	116	2	IPR004273
Domain	Znf_RING	RNF213 TRIM64 TRIM59 TRIM64B UHRF1 UBR3 UHRF2	4.26e-03	326	116	7	IPR001841
Domain	Carb_anhydrase	PTPRG PTPRZ1	4.89e-03	17	116	2	PF00194
Domain	Carb_anhydrase	PTPRG PTPRZ1	4.89e-03	17	116	2	SM01057
Domain	-	PTPRG PTPRZ1	4.89e-03	17	116	2	3.10.200.10
Domain	ALPHA_CA_2	PTPRG PTPRZ1	4.89e-03	17	116	2	PS51144
Domain	Carbonic_anhydrase_a	PTPRG PTPRZ1	4.89e-03	17	116	2	IPR001148
Domain	SH2	SRC LCK STAT5A FER	4.92e-03	110	116	4	SM00252
Domain	SH2	SRC LCK STAT5A FER	5.08e-03	111	116	4	PS50001
Domain	SH2	SRC LCK STAT5A FER	5.24e-03	112	116	4	IPR000980
Domain	-	SRC LCK STAT5A FER	5.24e-03	112	116	4	3.30.505.10
Domain	Rib_L2_dom2	UHRF1 UHRF2	5.48e-03	18	116	2	IPR014722
Pathway	PID_PTP1B_PATHWAY	PDGFRB SRC LCK STAT5A FER	2.40e-05	52	94	5	M50
Pubmed	Large-scale structural analysis of the classical human protein tyrosine phosphatome.	PDGFRB LCK PTPN7 PTPRG PTPRM PTPRZ1	1.16e-08	47	116	6	19167335
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	ARID4B RBBP4 USP24 TUB DMXL1 HABP4 TENM4 A2ML1 FER TRMT1L PRRC2B	5.96e-07	475	116	11	31040226
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	USP34 TRPM4 RTCB DYNC2H1 PEX6 RNF213 SMPD4 ATP8B2 TRIM59 ARSL CELSR2 PTPRM MACF1 C5 PIGO	2.60e-06	1061	116	15	33845483
Pubmed	Tyrosine phosphorylation of tub and its association with Src homology 2 domain-containing proteins implicate tub in intracellular signaling by insulin.	SRC LCK TUB	2.99e-06	9	116	3	10455176
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	USP34 RBBP4 USP24 SLFN5 ARHGAP1 MRPS9 MACF1 USP15	5.04e-06	282	116	8	23667531
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DOCK3 DYNC2H1 RNF213 VARS2 LCMT2 ATP8B2 SHROOM4 UBR3 MACF1 PRDM16	6.38e-06	493	116	10	15368895
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	SEL1L USP34 GALNT2 RTCB PDGFRB IFI44 RNF213 BCKDHA RPS21 SLFN5 VARS2 LCMT2 NFU1 CELSR2 PSPC1 SF3A2 PIGO	6.57e-06	1451	116	17	30550785
Pubmed	The protein tyrosine kinase family of the human genome.	PDGFRB SRC LCK AATK FER	8.93e-06	83	116	5	11114734
Pubmed	Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib.	PDGFRB SRC	1.10e-05	2	116	2	18524994
Pubmed	Polymorphism of human Alpha class glutathione transferases.	GSTA1 GSTA2	1.10e-05	2	116	2	11668220
Pubmed	Human liver glutathione S-transferases: complete primary sequence of an Ha subunit cDNA.	GSTA1 GSTA2	1.10e-05	2	116	2	3800996
Pubmed	Nucleotide sequence of the human liver glutathione S-transferase subunit 1 cDNA.	GSTA1 GSTA2	1.10e-05	2	116	2	3678589
Pubmed	The basic glutathione S-transferases from human livers are products of separate genes.	GSTA1 GSTA2	1.10e-05	2	116	2	3036131
Pubmed	Fer tyrosine kinase oligomer mediates and amplifies Src-induced tumor progression.	SRC FER	1.10e-05	2	116	2	25867068
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4Y NLGN4X	1.10e-05	2	116	2	23183221
Pubmed	The extended catalysis of glutathione transferase.	GSTA1 GSTA2	1.10e-05	2	116	2	21163259
Pubmed	Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.	NLGN4Y NLGN4X	1.10e-05	2	116	2	24855039
Pubmed	Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form.	GSTA1 GSTA2	1.10e-05	2	116	2	15128049
Pubmed	Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.	NLGN4Y NLGN4X	1.10e-05	2	116	2	37001827
Pubmed	Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression.	GSTA1 GSTA2	1.10e-05	2	116	2	11692074
Pubmed	Dynamic, sex-differential STAT5 and BCL6 binding to sex-biased, growth hormone-regulated genes in adult mouse liver.	BCL6 STAT5A	1.10e-05	2	116	2	22158971
Pubmed	Modulation of expressivity in PDGFRB-related infantile myofibromatosis: a role for PTPRG?	PDGFRB PTPRG	1.10e-05	2	116	2	25158255
Pubmed	Evidence that glutathione S-transferases B1B1 and B2B2 are the products of separate genes and that their expression in human liver is subject to inter-individual variation. Molecular relationships between the B1 and B2 subunits and other Alpha class glutathione S-transferases.	GSTA1 GSTA2	1.10e-05	2	116	2	2604726
Pubmed	Isolation of a cDNA clone and localization of human glutathione S-transferase 2 genes to chromosome band 6p12.	GSTA1 GSTA2	1.10e-05	2	116	2	3031680
Pubmed	Activation of SRC kinase and phosphorylation of signal transducer and activator of transcription-5 are required for decidual transformation of human endometrial stromal cells.	SRC STAT5A	1.10e-05	2	116	2	18063684
Pubmed	UHRF genes regulate programmed interdigital tissue regression and chondrogenesis in the embryonic limb.	UHRF1 UHRF2	1.10e-05	2	116	2	31024001
Pubmed	Unusually rapid evolution of Neuroligin-4 in mice.	NLGN4Y NLGN4X	1.10e-05	2	116	2	18434543
Pubmed	The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding.	PDGFRB SRC	1.10e-05	2	116	2	9010229
Pubmed	Genetic variation and haplotype structures of the glutathione S-transferase genes GSTA1 and GSTA2 in Japanese colorectal cancer patients.	GSTA1 GSTA2	1.10e-05	2	116	2	21844655
Pubmed	Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice.	NLGN4Y NLGN4X	1.10e-05	2	116	2	37080762
Pubmed	Autism Related Neuroligin-4 Knockout Impairs Intracortical Processing but not Sensory Inputs in Mouse Barrel Cortex.	NLGN4Y NLGN4X	1.10e-05	2	116	2	29106499
Pubmed	Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.	NLGN4Y NLGN4X	1.10e-05	2	116	2	26456829
Pubmed	Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro.	NLGN4Y NLGN4X	1.10e-05	2	116	2	24104404
Pubmed	Human glutathione S-transferases. The Ha multigene family encodes products of different but overlapping substrate specificities.	GSTA1 GSTA2	1.10e-05	2	116	2	3138230
Pubmed	Heterologous expression of recombinant human glutathione transferase A1-1 from a hepatoma cell line.	GSTA1 GSTA2	1.10e-05	2	116	2	1330133
Pubmed	STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas.	BCL6 STAT5A	1.10e-05	2	116	2	16819511
Pubmed	A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y.	NLGN4Y NLGN4X	1.10e-05	2	116	2	32243781
Pubmed	Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.	NLGN4Y NLGN4X	1.10e-05	2	116	2	22989184
Pubmed	Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance.	SRC LCK	1.10e-05	2	116	2	7685110
Pubmed	The role of GSTA2 polymorphisms and haplotypes in breast cancer susceptibility: a case-control study in the Portuguese population.	GSTA1 GSTA2	1.10e-05	2	116	2	19639209
Pubmed	Characterization of two novel subunits of the alpha-class glutathione S-transferases of human liver.	GSTA1 GSTA2	1.10e-05	2	116	2	8431482
Pubmed	UHRF1 downregulation promotes T follicular helper cell differentiation by increasing BCL6 expression in SLE.	BCL6 UHRF1	1.10e-05	2	116	2	33568199
Pubmed	IL-1 beta induces proMMP-9 expression via c-Src-dependent PDGFR/PI3K/Akt/p300 cascade in rat brain astrocytes.	PDGFRB SRC	1.10e-05	2	116	2	18315570
Pubmed	Palmitoylation-dependent endosomal localization of AATYK1A and its interaction with Src.	SRC AATK	1.10e-05	2	116	2	18691334
Pubmed	Substrate-trapping techniques in the identification of cellular PTP targets.	PDGFRB SRC STAT5A PTPRM	2.22e-05	49	116	4	15588985
Pubmed	Placentation defects are highly prevalent in embryonic lethal mouse mutants.	ADAMTS3 CYP11A1 SMPD4 NHLRC2 PRRC2B	2.55e-05	103	116	5	29539633
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	PTPRG ADAMDEC1 PTPRM PTPRZ1 AOC3 C5 TNXB	2.61e-05	257	116	7	16335952
Pubmed	Smooth Muscle-Specific BCL6+/- Knockout Abrogates Sex Bias in Chronic Hypoxia-Induced Pulmonary Arterial Hypertension in Mice.	BCL6 STAT5A	3.30e-05	3	116	2	30140283
Pubmed	Tumor necrosis factor-alpha activation of nuclear transcription factor-kappaB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of Ikappa Balpha.	SRC LCK	3.30e-05	3	116	2	9792645
Pubmed	UV-induced activation of ATR is mediated by UHRF2.	UHRF1 UHRF2	3.30e-05	3	116	2	33848395
Pubmed	Novel RPTPγ and RPTPζ splice variants from mixed neuron-astrocyte hippocampal cultures as well as from the hippocampi of newborn and adult mice.	PTPRG PTPRZ1	3.30e-05	3	116	2	38952869
Pubmed	Structure and expression of the murine ADAM 15 gene and its splice variants, and difference of interaction between their cytoplasmic domains and Src family proteins.	SRC LCK	3.30e-05	3	116	2	13679040
Pubmed	DNA polymerases eta and kappa exchange with the polymerase delta holoenzyme to complete common fragile site synthesis.	POLD1 POLK	3.30e-05	3	116	2	28605669
Pubmed	PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma.	PDGFRB STAT5A	3.30e-05	3	116	2	36045346
Pubmed	Protein tyrosine phosphatase zeta/RPTPbeta interacts with PSD-95/SAP90 family.	PTPRG PTPRZ1	3.30e-05	3	116	2	10521598
Pubmed	Molecular investigation of the tandem Tudor domain and plant homeodomain histone binding domains of the epigenetic regulator UHRF2.	UHRF1 UHRF2	3.30e-05	3	116	2	34766381
Pubmed	The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells.	SRC FER	3.30e-05	3	116	2	9748248
Pubmed	Tyrosine phosphorylation of I kappa B alpha activates NF kappa B through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation.	SRC LCK	3.30e-05	3	116	2	12429743
Pubmed	Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha.	SRC LCK	3.30e-05	3	116	2	8797825
Pubmed	Evolution of the Autism-Associated Neuroligin-4 Gene Reveals Broad Erosion of Pseudoautosomal Regions in Rodents.	NLGN4Y NLGN4X	3.30e-05	3	116	2	32011705
Pubmed	TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells.	PDGFRB SRC	3.30e-05	3	116	2	17158602
Pubmed	Comparative expression of two alpha class glutathione S-transferases in human adult and prenatal liver tissues.	GSTA1 GSTA2	3.30e-05	3	116	2	12093480
Pubmed	Analysis of the neuroligin 4Y gene in patients with autism.	NLGN4Y NLGN4X	3.30e-05	3	116	2	18628683
Pubmed	Cloning and expression of a human CDC42 GTPase-activating protein reveals a functional SH3-binding domain.	SRC ARHGAP1	3.30e-05	3	116	2	8253717
Pubmed	BCCIP associates with the receptor protein tyrosine phosphatase PTPmu.	SRC PTPRM	3.30e-05	3	116	2	18773424
Pubmed	Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina.	NLGN4Y NLGN4X	3.30e-05	3	116	2	21282647
Pubmed	Early B cell factor 4 modulates FAS-mediated apoptosis and promotes cytotoxic function in human immune cells.	STAT5A EBF4	3.30e-05	3	116	2	35939714
Pubmed	Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.	BCL6 STAT5A	3.30e-05	3	116	2	20124477
Pubmed	Lineage-specific biology revealed by a finished genome assembly of the mouse.	TRIM64 TRIM64B MACF1 PRDM16	3.51e-05	55	116	4	19468303
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	RTCB RBBP4 USP24 RPS21 BABAM2 AMOTL1 TRMT1L PATJ USP15 PRRC2B	4.23e-05	615	116	10	31048545
Pubmed	Cold-inducible RBM3 inhibits PERK phosphorylation through cooperation with NF90 to protect cells from endoplasmic reticulum stress.	USP34 MRPS9 UBR3 SF3A2	4.96e-05	60	116	4	26472337
Pubmed	Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases.	USP34 USP24 PAN2	6.10e-05	23	116	3	14715245
Pubmed	Role of the transcriptional regulator SP140 in resistance to bacterial infections via repression of type I interferons.	SP110 SP140L	6.59e-05	4	116	2	34151776
Pubmed	RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef.	SRC LCK	6.59e-05	4	116	2	9778343
Pubmed	Genome-wide Analysis Identifies Bcl6-Controlled Regulatory Networks during T Follicular Helper Cell Differentiation.	BCL6 STAT5A	6.59e-05	4	116	2	26876184
Pubmed	MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.	PDGFRB SRC	6.59e-05	4	116	2	27259262
Pubmed	Structure and organization of the human alpha class glutathione S-transferase genes and related pseudogenes.	GSTA1 GSTA2	6.59e-05	4	116	2	8307579
Pubmed	Exceptional activity of murine glutathione transferase A1-1 against (7R,8S)-dihydroxy-(9S,10R)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene-induced DNA damage in stably transfected cells.	GSTA1 GSTA2	6.59e-05	4	116	2	12557262
Pubmed	Complementary DNA cloning, messenger RNA expression, and induction of alpha-class glutathione S-transferases in mouse tissues.	GSTA1 GSTA2	6.59e-05	4	116	2	1728405
Pubmed	Glutathione S-transferase A1 (GSTA1) release, an early indicator of acute hepatic injury in mice.	GSTA1 GSTA2	6.59e-05	4	116	2	24964013
Pubmed	Regulation of mouse glutathione S-transferases by chemoprotectors. Molecular evidence for the existence of three distinct alpha-class glutathione S-transferase subunits, Ya1, Ya2, and Ya3, in mouse liver.	GSTA1 GSTA2	6.59e-05	4	116	2	2049074
Pubmed	Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.	DYNC2H1 RNF213	6.59e-05	4	116	2	26147384
Pubmed	Glutathione S-transferase A1 - a sensitive marker of alcoholic injury on primary hepatocytes.	GSTA1 GSTA2	6.59e-05	4	116	2	27198676
Pubmed	Tau interacts with src-family non-receptor tyrosine kinases.	SRC LCK	6.59e-05	4	116	2	9763511
Pubmed	The protein tyrosine phosphatases PTPRZ and PTPRG bind to distinct members of the contactin family of neural recognition molecules.	PTPRG PTPRZ1	6.59e-05	4	116	2	20133774
Pubmed	A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.	PDGFRB SRC	6.59e-05	4	116	2	23651497
Pubmed	Mouse glutathione S-transferase Ya subunit: gene structure and sequence.	GSTA1 GSTA2	6.59e-05	4	116	2	3652905
Pubmed	Interindividual variation and organ-specific patterns of glutathione S-transferase alpha, mu, and pi expression in gastrointestinal tract mucosa of normal individuals.	GSTA1 GSTA2	6.59e-05	4	116	2	12139976
Pubmed	Cloning, expression, and biochemical characterization of a functionally novel alpha class glutathione S-transferase with exceptional activity in the glutathione conjugation of (+)-anti-7,8-dihydroxy-9,10-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene.	GSTA1 GSTA2	6.59e-05	4	116	2	9606968
Pubmed	5'-flanking sequence of mouse glutathione S-transferase Ya gene.	GSTA1 GSTA2	6.59e-05	4	116	2	2893339
Pubmed	Comparative biochemical analysis of UHRF proteins reveals molecular mechanisms that uncouple UHRF2 from DNA methylation maintenance.	UHRF1 UHRF2	6.59e-05	4	116	2	29506131
Pubmed	Comparison of CD45 extracellular domain sequences from divergent vertebrate species suggests the conservation of three fibronectin type III domains.	PTPRG PTPRM	6.59e-05	4	116	2	8759740
Pubmed	In situ hybridization of a rat cDNA probe for glutathione S-transferase gene Ya subunit (GST Ya) to rat chromosome 8.	GSTA1 GSTA2	6.59e-05	4	116	2	1526290
Pubmed	Essential roles of ERKs and p38K in up-regulation of GST A1 expression by Maotai content in human hepatoma cell line Hep3B.	GSTA1 GSTA2	6.59e-05	4	116	2	16786188
Pubmed	STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation.	LCK STAT5A	6.59e-05	4	116	2	9880255
Pubmed	Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects.	PDGFRB RNF213	6.59e-05	4	116	2	23769926
Pubmed	Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.	NLGN4Y NLGN4X	6.59e-05	4	116	2	12669065
Pubmed	Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm.	SRC LCK	6.59e-05	4	116	2	20100835
Pubmed	Homodimerization and isoform-specific heterodimerization of neuroligins.	NLGN4Y NLGN4X	6.59e-05	4	116	2	22671294
Pubmed	Ultrasonic vocalizations in mouse models for speech and socio-cognitive disorders: insights into the evolution of vocal communication.	NLGN4Y NLGN4X	6.59e-05	4	116	2	20579107
Cytoband	11q14.3	TRIM64 TRIM64B AMOTL1	7.39e-05	32	116	3	11q14.3
Cytoband	6p12.1	GSTA1 GSTA2 TINAG	8.11e-05	33	116	3	6p12.1
Cytoband	20q13.3	RPS21 CDH4	1.17e-03	20	116	2	20q13.3
Cytoband	3q27	BCL6 MAP3K13	1.83e-03	25	116	2	3q27
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRG PTPRM PTPRZ1	1.13e-04	21	82	3	813
GeneFamily	Ubiquitin specific peptidases	USP34 USP24 PAN2 USP15	1.21e-04	56	82	4	366
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	A2ML1 C5	7.17e-04	9	82	2	1234
GeneFamily	PHD finger proteins	SP110 SP140L UHRF1 UHRF2	7.47e-04	90	82	4	88
GeneFamily	SH2 domain containing	SRC LCK STAT5A FER	1.15e-03	101	82	4	741
GeneFamily	Ring finger proteins	RNF213 TRIM64 TRIM59 TRIM64B UHRF1 UHRF2	1.56e-03	275	82	6	58
GeneFamily	Glycosyl transferases group 1 domain containing\|Phosphatidylinositol glycan anchor biosynthesis	PIGQ PIGO	4.03e-03	21	82	2	680
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN	RTCB SRC IFI44 RNF213 SLFN5 SP110 SP140L MAML2	2.70e-06	196	116	8	M4267
Coexpression	GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN	IFI44 ATP8B2 RPS6KA6 ARHGAP29 PAN2 IL17RA USP15 PRDM16	3.14e-06	200	116	8	M7495
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	VWF PDGFRB DYNC2H1 TENM4 NLGN4X ARHGAP29 MAML2 TNXB	4.07e-08	192	116	8	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 ARID4B IFI44 RNF213 SLFN5 SP110 MACF1 USP15	5.58e-08	200	116	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Control-Endothelial_cells-Endothelial_cells_(general)\|Control / group, cell type (main and fine annotations)	VWF SHROOM4 NLGN4X PTPRG PTPRM ARHGAP29 BTNL9	6.09e-07	187	116	7	fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCell	Control-Endothelial_cells\|Control / group, cell type (main and fine annotations)	VWF SHROOM4 PTPRG PTPRM TLL1 ARHGAP29 BTNL9	6.32e-07	188	116	7	3953b08abfea93468fc8d177bdb16ca7c6ffa1ab
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	VWF SHROOM4 NLGN4X PTPRG PTPRM ARHGAP29 BTNL9	6.78e-07	190	116	7	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	VWF SHROOM4 PTPRG PTPRM TLL1 ARHGAP29 BTNL9	6.78e-07	190	116	7	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 BABAM2 PTPRG PTPRM MACF1 MAML2 PATJ	7.27e-07	192	116	7	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FRAS1 PDGFRB TUB TENM4 PTPRG ADAMDEC1 TLL1	7.53e-07	193	116	7	cf2461af78f65616ce40d552ee9452295e3895ed
ToppCell	COPD-Endothelial-VE_Arterial\|COPD / Disease state, Lineage and Cell class	VWF SHROOM4 PTPRG PTPRM TLL1 ARHGAP29 BTNL9	7.53e-07	193	116	7	1c701b6ab5f0f0239634adac94fa1c92bf3c36f4
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FRAS1 PDGFRB TUB TENM4 PTPRG ADAMDEC1 TLL1	7.53e-07	193	116	7	6ef9007c9d18fb775d08fb20cdf954a28d54d7eb
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VWF SHROOM4 NLGN4X PTPRG PTPRM ARHGAP29 BTNL9	7.53e-07	193	116	7	ad3f4fcc8e2816d696cbcde744dc16500e51ccac
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FRAS1 PDGFRB TUB TENM4 PTPRG ADAMDEC1 TLL1	7.53e-07	193	116	7	e4ea7ce011a80b81b841c907719aa532bed39d2e
ToppCell	COVID-19_Severe-CD4+_T_activated\|World / disease group, cell group and cell class	IFI44 RPS21 SLFN5 LCK ATP8B2 MAML2 PATJ	8.07e-07	195	116	7	61d2d6c2d59799b3d877e622ccbcee9e84703a35
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 FRAS1 ARID4B USP24 RNF213 MACF1 UHRF2	8.64e-07	197	116	7	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	VWF SHROOM4 NLGN4X PTPRG PTPRM ARHGAP29 BTNL9	9.56e-07	200	116	7	ac6b8bc9998d303f788511b8f111e682ea9f3df8
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	USP34 VWF RNF213 PTPRG PTPRM ARHGAP29 MACF1	9.56e-07	200	116	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH2 IFI44 DEPDC1 LCK PTPRG BTNL9	1.24e-06	131	116	6	419a0a83b38eaea890d065c3f252ef83c2d37b5b
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DEPDC1 CSMD2 NLGN4X PTPRG PTPRZ1 UHRF1	6.62e-06	175	116	6	cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9
ToppCell	10x_5'_v1-Neoplastic-Stem-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DEPDC1 CSMD2 NLGN4X PTPRG PTPRZ1 UHRF1	6.62e-06	175	116	6	a8400e7e47379901dcab5f2e364c3ff17765b4b9
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DEPDC1 CSMD2 NLGN4X PTPRG PTPRZ1 UHRF1	6.62e-06	175	116	6	8a3abf40146ae3459d97cdf865c1c8f6b92ac639
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DEPDC1 CSMD2 NLGN4X PTPRG PTPRZ1 UHRF1	6.62e-06	175	116	6	378d2b79edac91fc74eee0fb42bb29dd9b07c36f
ToppCell	URO-Lymphocyte-T_NK-CD4_TCM\|URO / Disease, Lineage and Cell Type	RPS21 SLFN5 LCK ATP8B2 CACNA1I PATJ	7.53e-06	179	116	6	cdf972acf23c7a22c99a336ee0f9cc51e0fa6f67
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VWF PDGFRB TENM4 NLGN4X PTPRG TNXB	8.28e-06	182	116	6	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	COVID-19-kidney-Mito-rich_EC\|kidney / Disease (COVID-19 only), tissue and cell type	VWF IFI44 SLFN5 TLL1 BTNL9 TNXB	8.54e-06	183	116	6	3c4153479fc4ab2d073d92cee120480015555914
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	ARID4B IFI44 RNF213 SLFN5 SP110 SP140L	8.54e-06	183	116	6	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	VWF PTPRG PTPRM TLL1 ARHGAP29 BTNL9	8.81e-06	184	116	6	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF PDGFRB SLC12A5 PTPRM PTPRZ1 AMOTL1	9.09e-06	185	116	6	f98af3146ec2f44c30d31a662fb9c4fa3ca4f706
ToppCell	droplet-Bladder-nan-24m-Endothelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF DNAH2 SLFN5 PTPRM TLL1 ARHGAP29	9.09e-06	185	116	6	90caab8d9361a541c5d5121c97c3f1cdffeeae4a
ToppCell	COPD-Endothelial-VE_Arterial\|World / Disease state, Lineage and Cell class	VWF PTPRG PTPRM TLL1 ARHGAP29 BTNL9	9.66e-06	187	116	6	be42ee71d3412bb1f52593d8814de85c354a0efa
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	VWF SHROOM4 PTPRG PTPRM TLL1 ARHGAP29	9.66e-06	187	116	6	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 COLEC10 BCL6 PTPRG ARHGAP29 PATJ	9.66e-06	187	116	6	c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCell	COVID-19-lung-Artery_EC\|lung / Disease (COVID-19 only), tissue and cell type	VWF PTPRG PTPRM TLL1 ARHGAP29 BTNL9	9.96e-06	188	116	6	eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VWF SHROOM4 PTPRG PTPRM ARHGAP29 BTNL9	9.96e-06	188	116	6	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IFI44 SLFN5 PTPRG PTPRM ARHGAP29 BTNL9	9.96e-06	188	116	6	20072a2a3f9ecbe727c850629f19420cf60e4bc5
ToppCell	facs-Trachea-3m-Endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IFI44 SLFN5 PTPRG PTPRM ARHGAP29 BTNL9	9.96e-06	188	116	6	dd817059e1b4225e84733559f7839cc973b7dfd6
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IFI44 SLFN5 PTPRG PTPRM ARHGAP29 BTNL9	9.96e-06	188	116	6	6ab5ce8569f896a0fe7a76b8b4a83661e5499b8c
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	VWF PTPRG PTPRM TLL1 ARHGAP29 BTNL9	1.03e-05	189	116	6	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	facs-Trachea-nan-3m-Endothelial\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFI44 SLFN5 PTPRG PTPRM ARHGAP29 BTNL9	1.03e-05	189	116	6	f60ac60ab9b317a0196f0cbbe520ef7dbd19ac11
ToppCell	facs-Heart-LV-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFI44 SLFN5 PTPRG PTPRM ARHGAP29 BTNL9	1.03e-05	189	116	6	d424d2554595b2304219f7324406b401711af7c2
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFI44 SLFN5 PTPRG PTPRM ARHGAP29 BTNL9	1.03e-05	189	116	6	393ec5954a12d6cf67bb435dcc34ff0b14c81e9f
ToppCell	facs-Trachea-nan-3m-Endothelial-endothelial_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFI44 SLFN5 PTPRG PTPRM ARHGAP29 BTNL9	1.03e-05	189	116	6	e3d65417997bdd3f9c312c0977dceb6eca061029
ToppCell	facs-Liver-Non-hepatocytes-3m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POLD1 RPS21 LCK SP110 TRIM59 PTPN7	1.03e-05	189	116	6	039b1922c85aa749d6578583d9d41a4eef8a6ac4
ToppCell	facs-Trachea-nan-3m-Endothelial-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFI44 SLFN5 PTPRG PTPRM ARHGAP29 BTNL9	1.03e-05	189	116	6	5559af03d9d612bb8dcf825e45744a9f8332bac8
ToppCell	facs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IFI44 SLFN5 PTPRG PTPRM ARHGAP29 BTNL9	1.03e-05	189	116	6	bec57459ad4bab15b2532b57722549fec2e771fb
ToppCell	facs-Thymus-Epithelium-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP11A1 VARS2 GSTA2 PATJ UHRF2	1.03e-05	110	116	5	3a641dced828ed97a8eea70d0a7b76f33630c9be
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FRAS1 SHROOM4 PTPRM C5 PATJ PRDM16	1.06e-05	190	116	6	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 COLEC10 BCL6 PTPRG ARHGAP29 PATJ	1.06e-05	190	116	6	1cf023e3c6924d6a06f353d4b62444b6f2fee8a7
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDGFRB TRIM59 SHROOM4 PTPRZ1 MAML2 PRDM16	1.06e-05	190	116	6	2de8e4cfeee350a9a76af749d6ce58d948c129b8
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 COLEC10 BCL6 PTPRG ARHGAP29 PATJ	1.06e-05	190	116	6	59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a
ToppCell	Calu_3-infected-SARSCoV2\|infected / Cell line, Condition and Strain	ARID4B IFI44 RNF213 SLFN5 SP110 SP140L	1.09e-05	191	116	6	2da876d26f37a00dbdf1ee79d724306e8b20f304
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	VWF SHROOM4 PTPRM TLL1 ARHGAP29 BTNL9	1.09e-05	191	116	6	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	VWF SHROOM4 PTPRM TLL1 ARHGAP29 BTNL9	1.12e-05	192	116	6	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VWF SHROOM4 PTPRG PTPRM ARHGAP29 BTNL9	1.16e-05	193	116	6	f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IFI44 RPS21 SLFN5 LCK ATP8B2 PATJ	1.16e-05	193	116	6	2901d7a9672a8cf70c9f1c752685b45e4d79ac70
ToppCell	IPF-Endothelial-VE_Arterial\|IPF / Disease state, Lineage and Cell class	VWF SHROOM4 PTPRG PTPRM ARHGAP29 BTNL9	1.16e-05	193	116	6	bf83b1fe9d38408f30eee4eb634341c04ef82791
ToppCell	Control-Endothelial-VE_Arterial\|World / Disease state, Lineage and Cell class	VWF SHROOM4 PTPRG TLL1 ARHGAP29 BTNL9	1.16e-05	193	116	6	52c0f2c7af57436f23e0c0e0c87086c47695e2c4
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated\|COVID-19_Severe / Disease group, lineage and cell class	IFI44 RPS21 SLFN5 LCK ATP8B2 PATJ	1.16e-05	193	116	6	beb862d38b88572836b0a797c8efef7a2492e0b9
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IFI44 RPS21 SLFN5 LCK ATP8B2 PATJ	1.16e-05	193	116	6	f4310faa13fc8ce99a217e2d1c9cc733683797a1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IFI44 RPS21 SLFN5 LCK ATP8B2 PATJ	1.16e-05	193	116	6	f8af695457d2a0a911a5ac491742465864ebda37
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	IFI44 RPS21 SLFN5 LCK ATP8B2 PATJ	1.16e-05	193	116	6	089aece40130034a89a5213be778f10b0787eeba
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VWF SHROOM4 PTPRG PTPRM ARHGAP29 BTNL9	1.19e-05	194	116	6	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	COPD-Endothelial-VE_Capillary_B\|World / Disease state, Lineage and Cell class	VWF SHROOM4 PTPRG PTPRM ARHGAP29 BTNL9	1.19e-05	194	116	6	68705a6eca947c5b42b943d5224a7aef2a744007
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF SHROOM4 PTPRG PTPRM ARHGAP29 MACF1	1.19e-05	194	116	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	COPD-Endothelial-VE_Capillary_B\|COPD / Disease state, Lineage and Cell class	VWF SHROOM4 PTPRG PTPRM ARHGAP29 BTNL9	1.19e-05	194	116	6	18b7f901c12ca4f21f9a1eafd092aefe4d668b6d
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DOCK3 FRAS1 PTPRZ1 TLL1 PATJ PRDM16	1.19e-05	194	116	6	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	VWF SHROOM4 PTPRM TLL1 ARHGAP29 BTNL9	1.23e-05	195	116	6	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	Parenchymal-NucSeq-Stromal-Mesofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FRAS1 ADAMTS3 BCKDHA NLGN4X PTPRZ1 TNXB	1.23e-05	195	116	6	a52685f76eca269a7d2de8dfc317439483e233fa
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VWF SHROOM4 PTPRG PTPRM TLL1 ARHGAP29	1.23e-05	195	116	6	023e3c97dd3696d74f002ff8da0c04d876c82aef
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	VWF IFI44 SHROOM4 PTPRM ARHGAP29 BTNL9	1.23e-05	195	116	6	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	B_cells-ISG-high_B_cells\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	RTCB IFI44 RNF213 SLFN5 SP110 DMXL1	1.23e-05	195	116	6	b64d9e1a8834401b4dc501566546647754ae21fc
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	VWF IFI44 SHROOM4 PTPRM ARHGAP29 BTNL9	1.23e-05	195	116	6	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FRAS1 ADAMTS3 BCKDHA NLGN4X PTPRZ1 TNXB	1.23e-05	195	116	6	224deeba2f60def6543a55bb4f5ee6c7fdab3f02
ToppCell	healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	RNF213 SLFN5 LCK ATP8B2 PTPN7 MACF1	1.26e-05	196	116	6	af00c31612e4fe068e5fccae05368edba46bbd20
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF PTPRG PTPRM TLL1 ARHGAP29 BTNL9	1.26e-05	196	116	6	cf7f384c1771274e766bab03ecc3dfbd13f2df60
ToppCell	nucseq-Endothelial-Endothelial_Vascular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VWF SHROOM4 PTPRG PTPRM ARHGAP29 BTNL9	1.26e-05	196	116	6	686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	VWF SHROOM4 NLGN4X PTPRM ARHGAP29 BTNL9	1.30e-05	197	116	6	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	healthy_donor-Lymphocytic-T_cell-CD4+_Naive_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	RPS21 SLFN5 ATP8B2 CACNA1I MAML2 PATJ	1.30e-05	197	116	6	cf72160f03105876641fa6fdc7405e339eb084c7
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	VWF SHROOM4 PTPRM TLL1 ARHGAP29 BTNL9	1.30e-05	197	116	6	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	COVID_vent-Lymphocytic-T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	RPS21 SLFN5 LCK ATP8B2 MACF1 PATJ	1.30e-05	197	116	6	ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e
ToppCell	COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	RNF213 SLFN5 LCK PTPN7 PTPRM MACF1	1.30e-05	197	116	6	d4dfb3b561d0783cdbee4e8d27009ad81df695cb
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	USP34 VWF PDGFRB PTPRG ARHGAP29 BTNL9	1.34e-05	198	116	6	0a4626b51ba8b52acbaf616f0ced850079cd7149
ToppCell	ASK452-Endothelial-Endothelium\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	VWF IFI44 SHROOM4 PTPRM ARHGAP29 BTNL9	1.34e-05	198	116	6	e282769f5fa1765bcce79a0ed9d761bf2e14b012
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF PTPRG PTPRM TLL1 ARHGAP29 BTNL9	1.34e-05	198	116	6	9e103228ac2cc86eec58bc6b8e142965228e8853
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF SHROOM4 NLGN4X PTPRM ARHGAP29 BTNL9	1.34e-05	198	116	6	d5990cab01de6e6f3757f5a50ef70ced711bb1fa
ToppCell	wk_08-11-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	FRAS1 ARSL PTPRZ1 C5 PATJ PRDM16	1.34e-05	198	116	6	84697f316d9195ebe838cf57f4dbdd9feea43bec
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	VWF IFI44 PTPRM TLL1 BTNL9 TNXB	1.34e-05	198	116	6	953630dbe3154b1b102b87de0feca2cbf124eabe
ToppCell	COVID-19-lung-Capillary_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VWF SHROOM4 PTPRM TLL1 ARHGAP29 BTNL9	1.34e-05	198	116	6	45419f2804b4be79bae6632e71c54e1af482d115
ToppCell	wk_08-11-Epithelial-Distal_epithelial_progenitor\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	FRAS1 ARSL PTPRZ1 C5 PATJ PRDM16	1.34e-05	198	116	6	eda85a592527992b51a00f288cff0c3239c47e6f
ToppCell	CV-Mild-1\|CV / Virus stimulation, Condition and Cluster	IFI44 RNF213 RPS21 SLFN5 SP110 USP15	1.34e-05	198	116	6	4b078714c49e7befb7b113d72485e712236d35fa
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	VWF IFI44 PTPRM TLL1 BTNL9 TNXB	1.34e-05	198	116	6	8e45551224fbb30c0658ad47dd98335ecf165437
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF PTPRG PTPRM TLL1 ARHGAP29 BTNL9	1.34e-05	198	116	6	12697db1e516c2afdb5fa1ca8caa06f4abed3382
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	VWF SHROOM4 PTPRM TLL1 ARHGAP29 BTNL9	1.38e-05	199	116	6	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 USP24 IFI44 RNF213 MACF1 USP15	1.38e-05	199	116	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	BAL-Severe-cDC_1\|Severe / Compartment, Disease Groups and Clusters	RTCB IFI44 RNF213 SLFN5 SP110 IL17RA	1.38e-05	199	116	6	9f5750212b887f92761ade33fc6e108cd5275297
ToppCell	BAL-Mild-cDC_1\|Mild / Compartment, Disease Groups and Clusters	RTCB IFI44 RNF213 SP110 SP140L USP15	1.38e-05	199	116	6	c55181bdec8952b54198f0d4c9c5c84265b16572
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	FRAS1 COLEC10 PTPRG PTPRM ARHGAP29 MACF1	1.38e-05	199	116	6	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	mild-CD4+_Tcm\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID4B IFI44 SLFN5 LCK ATP8B2 MACF1	1.38e-05	199	116	6	06c8a0e39f7a33736548f04a5e2263334c8541cf
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_T_cell\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RPS21 SLFN5 LCK ATP8B2 MAML2 PATJ	1.38e-05	199	116	6	551f4f4364a711efe133d38e29cd43c78bffaaa1
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	VWF RNF213 SHROOM4 PTPRM ARHGAP29 MACF1	1.41e-05	200	116	6	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOK6 FRAS1 SLC12A5 ABCG4 SLC7A4 CACNA1I	1.41e-05	200	116	6	2f481e2fd248c02a5aa2e0248c16808df142fed2
Drug	bosutinib	PDGFRB SRC LCK STAT5A MLN	2.11e-06	42	114	5	CID005328940
Disease	coronary artery disease	GALNT2 ADAMTS3 DYNC2H1 RNF213 TUB NFU1 DMXL1 CELSR2 FER PAN2 MLN UHRF1 C5 PRDM16 TNXB FOXL1	1.15e-05	1194	112	16	EFO_0001645
Disease	1,3,7-trimethylurate measurement	FRAS1 GSTA1 GSTA2	2.34e-05	15	112	3	EFO_0021172
Disease	cholangiocarcinoma, sclerosing cholangitis	DOCK3 SP110	1.42e-04	5	112	2	EFO_0004268, EFO_0005221
Disease	free cholesterol to total lipids in large LDL percentage	GALNT2 CELSR2 MACF1 POLK	1.84e-04	74	112	4	EFO_0022280
Disease	colorectal cancer (implicated_via_orthology)	POLD1 SRC LCK	2.01e-04	30	112	3	DOID:9256 (implicated_via_orthology)
Disease	asparagine measurement	FRAS1 ASNS A2ML1	5.11e-04	41	112	3	EFO_0009766
Disease	platelet component distribution width	DOK6 VWF GALNT2 NHLRC2 HABP4 MACF1 POLK USP15 PRDM16 TNXB	6.15e-04	755	112	10	EFO_0007984
Disease	intraocular pressure measurement	SEL1L DYNC2H1 BABAM2 KLHL38 TLL1 FER PRDM16 TNXB	7.37e-04	509	112	8	EFO_0004695
Disease	metabolic rate measurement	SP110 FOXL1	7.68e-04	11	112	2	EFO_0005115
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	GALNT2 USP24 NHLRC2 TENM4 CELSR2 MACF1	8.72e-04	291	112	6	EFO_0008317, EFO_0020946
Disease	triglycerides to total lipids in medium LDL percentage	GALNT2 CELSR2 POLK	9.16e-04	50	112	3	EFO_0022334
Disease	progression free survival, urinary bladder cancer	DOK6 TENM4	9.19e-04	12	112	2	EFO_0004920, MONDO_0001187
Disease	triglycerides to total lipids in large LDL percentage	GALNT2 CELSR2 POLK	9.71e-04	51	112	3	EFO_0022331
Disease	platelet crit	VWF GALNT2 ARID4B NHLRC2 GSTA1 HABP4 PTPN7 TADA2B ARHGAP29 USP15 PRDM16	1.01e-03	952	112	11	EFO_0007985
Disease	depressive symptom measurement	VWF GALNT2 SLC12A5 AATK PTPRG MLN TNXB	1.23e-03	426	112	7	EFO_0007006
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	ADAMTS3 CELSR2	1.26e-03	14	112	2	EFO_0004611, EFO_0008589
Disease	cholesterol to total lipids in IDL percentage	GALNT2 MACF1 POLK	1.56e-03	60	112	3	EFO_0022233
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	GALNT2 USP24 NHLRC2 CELSR2 MACF1	1.71e-03	225	112	5	EFO_0008317, EFO_0020947
Disease	methadone dose measurement	MAML2 PATJ PSPC1	1.71e-03	62	112	3	EFO_0007907
Disease	retinopathy	SRC TENM4	1.87e-03	17	112	2	EFO_0003839
Disease	bacteriemia	DOCK3 PTPRG	1.87e-03	17	112	2	EFO_0003033
Disease	Headache	RNF213 MACF1 PRDM16	1.87e-03	64	112	3	HP_0002315
Disease	cholesteryl esters to total lipids in medium VLDL percentage	GALNT2 CELSR2 POLK	1.87e-03	64	112	3	EFO_0022253
Disease	androstenedione measurement, estrone measurement	GALNT2 PTPRM	2.10e-03	18	112	2	EFO_0007970, EFO_0007972
Disease	level of Sphingomyelin (d34:1) in blood serum	ADAMTS3 USP24	2.10e-03	18	112	2	OBA_2045175
Disease	X-11470 measurement	VARS2 TNXB	2.34e-03	19	112	2	EFO_0021241
Disease	proprotein convertase subtilisin/kexin type 9 measurement	USP24 IFI44	3.14e-03	22	112	2	EFO_0009312
Disease	body weight loss	GALNT2 CDH4	3.14e-03	22	112	2	EFO_0005245
Disease	body surface area	ADAMTS3 BCL6 HABP4 AATK PTPRG UHRF1 MACF1 PATJ	3.19e-03	643	112	8	EFO_0022196
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	GALNT2 USP24 NHLRC2 CELSR2 MACF1	3.40e-03	264	112	5	EFO_0008317, EFO_0020944
Disease	QRS duration, response to sulfonylurea	TINAG UQCC1	3.43e-03	23	112	2	EFO_0005055, EFO_0007922

Protein segments in the cluster

Peptide	Gene	Start	Entry
INLMRPGVFTDIEQY	PTPRG	1386	P23470
PEERENFLQQLYKFM	ARID4B	306	Q4LE39
EAQVQYPLQTFAIGM	ASNS	276	P08243
EYGDLNPMLFRAVQN	ABCG4	316	Q9H172
YQEQQELPGRQMPAF	BTNL9	86	Q6UXG8
EPVFYQVMERVQQAV	ARSL	531	P51690
TFENPMYDRNIQPTD	CSMD2	3456	Q7Z408
PAVNYAVMFVDNRIQ	C19orf47	61	Q8N9M1
EGKFQMEDLVYNPEQ	A2ML1	416	A8K2U0
QEDPQMVYQSARQEP	AMOTL1	146	Q8IY63
REGQYMFTDNTPLQN	COLEC10	216	Q9Y6Z7
MLPYDVQIIDENGNV	ACSM4	396	P0C7M7
IMYQIVEGNIPEVFQ	CELSR2	956	Q9HCU4
HQQQYREDLFQIPMV	SLC7A4	531	O43246
YIEEQLLQRIPEFNM	ARL2BP	76	Q9Y2Y0
LDEYQPGMFRQVQVS	DMXL1	511	Q9Y485
YLDIDQMIFNRELPQ	AOC3	176	Q16853
GVFDQDVPEQRSMEY	ATP8B2	941	P98198
YIQQGLVRQDAEPMF	RAB3IL1	346	Q8TBN0
NDGYLMFQQVPMVEI	GSTA1	46	P08263
EEETYGPFQIRIQDM	PTPN7	211	P35236
QADGQNMVEPLFYTV	OR5H15	266	A6NDH6
YRPLLQYVQDMGQED	CCNC	156	P24863
QDMQELEIPQAYRGA	PAN2	626	Q504Q3
EVYFRIQDLEMFQPG	IL17RA	531	Q96F46
QDYPQFGEVVLLVNM	FRAS1	1371	Q86XX4
NMLQFYIPEVEGVEQ	NFU1	226	Q9UMS0
PIIDVINMDNFQYVG	GALNT2	251	Q10471
ENYGPRAEVVMQDVA	HABP4	386	Q5JVS0
NDGYLMFQQVPMVEI	GSTA2	46	P09210
PELINMYVGQSEENV	PEX6	771	Q13608
NDMNNPTYVGFERDV	DEPDC1	261	Q5TB30
VQYMQDNGAVIPVRI	MAT1A	186	Q00266
NPEVIQNLERGYRMV	LCK	446	P06239
ANFVAPEVLMQQGYD	RPS6KA6	586	Q9UK32
MRPGVFADIEQYQFL	PTPRZ1	2261	P23471
VYEEPLIDIQQENAM	PLEKHM3	576	Q6ZWE6
PQGVAIMNNIIYVAD	NHLRC2	281	Q8NBF2
EEGIARNLINPQMYQ	MACF1	1601	Q9UPN3
QGRVNPVEYSIVMEF	SMPD4	111	Q9NXE4
INHEGEVNRARYMPQ	RBBP4	121	Q09028
EVEQYGPQENVHMFV	PASD1	246	Q8IV76
GQMTQENIFPNRYGD	MAML2	281	Q8IZL2
CVEERGYENPMQFEE	MAP3K13	926	O43283
DDPQILMEQGEFLNY	NLGN4Y	351	Q8NFZ3
RMQQFEDLEGEIPQF	ARHGAP29	1246	Q52LW3
YQMGLEALNENLPEI	DYNC2H1	761	Q8NCM8
NEEYFIEPLERGKQM	ADAMTS3	176	O15072
LNGNIRDRYQFNPME	IFI44	271	Q8TCB0
YDNIMEQQRLEPEFF	DOCK3	1341	Q8IZD9
EYQTLLEEPQYGENM	BABAM2	141	Q9NXR7
VQREQNERFNVYLMP	DOK6	131	Q6PKX4
FVLAMYDRQGQPVEV	EBF4	71	Q9BQW3
YPGMTNQQAREQVER	FER	761	P16591
MYNGLDAVAVDQQPV	CACNA1I	1386	Q9P0X4
EMNIPYSVVRGEQIQ	C5	826	P01031
YVIDMNDNRPEFINQ	CDH4	266	P55283
VNPEAQRFIDAIYQM	CYP11A1	226	P05108
PQDIMAYRGREVVEN	BCL6	151	P41182
PEQRVTLNGIYQFIM	FOXL1	66	Q12952
LMVNGQVESAQFPEY	B9D1	11	Q9UPM9
MGPFLTNYRDEIVNQ	DNAH2	3321	Q9P225
RIMDPDVITGYNIQN	POLD1	386	P28340
DDPQILMEQGEFLNY	NLGN4X	351	Q8N0W4
GQLVYGQLMEPVNRE	FAM171B	566	Q6P995
ELPMNEQFYNAIKRG	PDGFRB	906	P09619
DVYQEMPAQLRKQQE	BCKDHA	411	P12694
PQDGYRMVQQFQFLG	PTPRM	1336	P28827
PRNRNGDENYMEFLE	SLC12A5	1101	Q9H2X9
FVPNMQVEGVFYVND	RTCB	26	Q9Y3I0
QVYMELQGLVDPQIQ	VARS2	981	Q5ST30
YPGMVNREVLDQVER	SRC	466	P12931
FQKDGNMVEENPYRQ	TRMT1L	496	Q7Z2T5
MQNDAGEFVDLYVPR	RPS21	1	P63220
ENIQPGQEYNFLKME	TLL1	266	O43897
QQQLGYMPLRDDYEI	TADA2B	161	Q86TJ2
FGDYLPQNIQAAREM	SEL1L	231	Q9UBV2
EQMQFLEEVQPYRAL	AATK	166	Q6ZMQ8
DVVNNMYEPNRDLLA	PRDM16	16	Q9HAZ2
PGEDQVMLIFYDQRQ	PIGQ	121	Q9BRB3
REVQQKYNMGLPVDF	ARHGAP1	291	Q07960
FGMVSRYLPQDQLQD	SHROOM4	1436	Q9ULL8
ERQMQPQDQLIRDYG	SP110	596	Q9HB58
YPQVEGFVQDMRLIF	SP140L	526	Q9H930
EMGQQSLLFQIDYPE	SF3A2	126	Q15428
RQMQVLYGQHFPIEV	STAT5A	16	P42229
RYEPEVQYQMILNGE	ADAMDEC1	71	O15204
DVVMVNYNVESPGQR	UHRF2	246	Q96PU4
FVLQQPMIYEGQAQL	RNF213	561	Q63HN8
DREQAPNLVYMVTGN	VWF	1596	P04275
FVPIFTYGELQRMQE	MLN	26	P12872
LIEPVQYDEQGMAFS	MRPS9	256	P82933
ELRRQQEGFKPNYME	PSPC1	371	Q8WXF1
QEGFKPNYMENREQE	PSPC1	376	Q8WXF1
MAQGRQIEYIDIERP	PATJ	126	Q8NI35
VPEGQFDTFMVQYRD	TNXB	1181	P22105
GQYQILPNRQAVMDF	POLK	331	Q9UBT6
KYQEELNFDNPLGMR	USP15	321	Q9Y4E8
EPRVPFRQFQMNDQD	PRRC2B	311	Q5JSZ5
GEIYMDTNPNFQIII	TENM4	2386	Q6N022
EDVQQRGRVMGVNPY	UQCC1	181	Q9NVA1
DPVQRNLYQDVMLEN	ZNF234	26	Q14588
DLEVGQVVMLNYNPD	UHRF1	216	Q96T88
NVFDMLYQLANLEEP	USP24	1081	Q9UPU5
TQLEEMNPQLGYEEQ	UBR3	1511	Q6ZT12
VVPQIYRHMQEEFRG	PIGO	796	Q8TEQ8
QYPGAVEELFNLMQL	USP34	2891	Q70CQ2
VVYEQMRPQDAFGQF	LCMT2	216	O60294
NGPVQAIMQVREDFF	TINAG	371	Q9UJW2
QYQKMPIFLDEEEQR	TRIM64	181	A6NGJ6
QYQKMPIFLDEEEQR	TRIM64B	181	A6NI03
GNPVAENFRMEEVYL	PTGR2	16	Q8N8N7
ENFRMEEVYLPDNIN	PTGR2	21	Q8N8N7
QIIHGNDPDYIVMQF	TUB	456	P50607
NDPDYIVMQFGRVAE	TUB	461	P50607
GPIANYLQQVMQEAR	SLFN5	716	Q08AF3
YLQIFGQIPQEDMDV	TRPM4	971	Q8TD43
GNLINQEYTPQIERM	TRIM59	211	Q8IWR1
QRLYLFGGEDIMQNP	KLHL38	431	Q2WGJ6